CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Portugal
Summary
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Portugal. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Portugal. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Portugal. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Portugal’s efforts to reform its drug pricing policy led to significant reductions in pharmaceutical spending, thereby, resulting in a declining trend in the pharmaceutical market. In 2016, pharmaceutical sales decreased to $2.80 billion from $4.29 billion in 2010. The market is forecast to reach $1.83 billion in 2022, at a negative CAGR of 7%. In 2010, the medical device market in Portugal was worth $1.18 billion, which increased to $1.48 billion in 2017. The main segments were cardiovascular devices, in vitro diagnostics, ophthalmic devices, hospital supplies and orthopedic devices.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Portugal, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Merck, Bial, Pfizer, Astrazeneca and Novartis) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostics, DePuy Synthes, Alcon and Medbone)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Portugal
- Porter’s five forces analysis for pharmaceutical and medical devices market of Portugal
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Portuguese healthcare market.
Reasons to buyThis report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Portuguese healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Portuguese healthcare market.
- Executive Summary
- Overview of Pharmaceutical Market
- Overview of Medical Device Market
- Deals Analysis
- Porter’s Five Forces Model
- Market Access
- Country Healthcare Landscape
- Opportunities and Challenges
- Appendix
- List of Tables
- Table 1: Pharmaceutical Market, Number of wholesalers, Portugal, 2016
- Table 2: Pharmaceutical Market, Portugal, Self Medication Product Category Sales ($m), 2015
- Table 3: Pharmaceutical Market, Portugal, Major therapeutic groups based on drug sales ($m), 2016
- Table 4: Medical Device Market, Portugal, Revenue by Segment ($m) and share (%), 2017
- Table 5: Cardiovascular Devices Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2017
- Table 6: IVD Devices Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2017
- Table 7: Ophthalmic Devices Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2015
- Table 8: Hospital Supplies Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2014
- Table 9: Orthopedic Devices Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2017
- Table 10: Merger & Acquisition Deals, Medical Device Market, Portugal, 2017-2018
- Table 11: Private Equity, Deals, Medical Device Market, Portugal, 2017-2018
- Table 12: Drug Reimbursement , Portugal, 2017
- Table 13: NHS Expenditures on Medicines ($m) , Portugal, 2018
- Table 14: Patent Fees, Portugal, 2018
- Table 15: Trademark Fees, Portugal, 2018
- Table 16: Clinical Trial Process Fees, Portugal, 2018
- Table 17: Trade Fairs, Portugal
- List of Figures
- Figure 1: Pharmaceutical Market, Portugal, Revenue ($bn), 2010-2017
- Figure 2: Medical Device Market, Portugal, Revenue ($bn), 2010-2017
- Figure 3: Country Profile, Portugal, 2018
- Figure 4: Pharmaceutical Market, Portugal, Revenue ($bn), 2010-2017
- Figure 5: Pharmaceutical Market, Portugal, Revenue Forecast ($bn), 2018-2022
- Figure 6: Pharmaceutical Exports ($bn), Portugal, 2010-2017
- Figure 7: Top Export Partners, Portugal, 2017
- Figure 8: Pharmaceutical Imports ($bn), Portugal, 2010-2017
- Figure 9: Top Import Partners, Portugal, 2017
- Figure 10: Distribution Channels, Portugal
- Figure 11: Pharmaceutical Market, Portugal, Major therapeutic groups based on drug sales ($m), 2016
- Figure 12: Pharmaceutical Market, Portugal, Major Players
- Figure 13: Medical Device Market, Portugal, Revenue ($bn), 2010-2017
- Figure 14: Medical Device Market, Portugal, Revenue Forecast ($bn), 2018-2022
- Figure 15: Medical Device Market, Portugal, Revenue by Segment ($m), 2017
- Figure 16: Cardiovascular Devices Market, Portugal, Revenue ($m), 2010-2017
- Figure 17: Cardiovascular Devices Market, Portugal , Market Share of Major Players (%), 2017
- Figure 18: IVD Devices Market, Portugal, Revenue ($m), 2010-2017
- Figure 19: IVD Devices Market, Portugal, Market Share of Major Players (%), 2017
- Figure 20: Ophthalmic Devices Market, Portugal, Revenue ($m), 2010-2017
- Figure 21: Ophthalmic Devices Market, Portugal, Market Share of Major Players (%), 2015
- Figure 22: Hospital Supplies Market, Portugal, Revenue ($m), 2010-2017
- Figure 23: Hospital Supplies Market, Portugal, Market Share of Major Players (%), 2014
- Figure 24: Orthopedic Devices Market, Portugal, Revenue ($m), 2010-2017
- Figure 25: Orthopedic Devices Market, Portugal, Market Share of Major Companies (%), 2017
- Figure 26: Diagnostic Market, Portugal, Revenue ($bn), 2010-2017
- Figure 27: Diagnostic Market, Portugal, Revenue ($bn), 2018-2022
- Figure 28: Medical Device Market, Portugal, Revenue ($bn) of Major Companies, 2016
- Figure 29: Deal Value and Deal Count, Pharmaceutical Market, Portugal, 2017-2018
- Figure 30: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Portugal, 2017-2018
- Figure 31:Deal Value and Deal Count Sub-types, Pharmaceutical Market, Portugal, 2017-2018
- Figure 32: Top Therapy Area by Deal Value ($m), Pharmaceutical Market, Portugal, 2017-2018
- Figure 33: Top Five Therapy Area by Deal Number (M&A deals), Pharmaceutical Market,Portugal, 2017-2018
- Figure 34: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Portugal, 2017-2018
- Figure 35: Overview of Healthcare System, Portugal, 2017
- Figure 36: Drug Reimbursement Process , Portugal, 2017
- Figure 37: Out-of-Pocket Expenditure (% of total expenditure on health), Portugal, 2010-2017
- Figure 38: Change in Price Trend in Healthcare Sector (%), Portugal , 2010-2017
- Figure 39: INFARMED, Organizational structure, Portugal, 2018
- Figure 40: National Procedure for Market Authorization, Portugal, 2018
- Figure 41: Centralized Procedure, Portugal, 2018
- Figure 42: Decentralized Procedure, Portugal, 2018
- Figure 43: Mutual Recognition Procedure, Portugal, 2018
- Figure 44: Conformity Assessment of Class I Medical Devices, EU, 2018
- Figure 45: Conformity Assessment of Class IIa Medical Devices, EU, 2018
- Figure 46: Conformity Assessment of Class IIb Medical Devices, EU, 2018
- Figure 47: Conformity Assessment of Class III Medical Devices, EU, 2018
- Figure 48: Documents required for Manufacturing, Portugal, 2018
- Figure 49: Patent Approval Process, Portugal, 2018
- Figure 50: European Patent Approval Process, EU, 2018
- Figure 51: Unitary Patent Approval Process, EU, 2017
- Figure 52: Trademark Approval Process, Portugal, 2018
- Figure 53: Clinical Trial Regulation Process, Portugal, 2018
- Figure 54: Labelling and Packaging Regulations, Portugal, 2018
- Figure 55: Hospitals (number), Portugal, 2010-2017
- Figure 56: Hospital Bed by Type of Care (number), Portugal, 2010-2017
- Figure 57: Diagnostic Equipment (number), Portugal, 2010-2017
- Figure 58: Hospital Beds (per 1,000 population), Portugal, 2010 - 2017
- Figure 59: Life Expectancy (years), Portugal, 2010-2017
- Figure 60: Immunization Rate (%), Portugal, 2010-2017
- Figure 61: Major Causes of Mortality, No. of deaths (‘000), Portugal, 2012
- Figure 62: Major Causes of Male Mortality, No. of deaths (‘000), Portugal, 2015
- Figure 63: Major Causes of Female Mortality, No. of deaths (‘000), Portugal, 2015
- Figure 64: Disability-Adjusted Life Years by Major Disease (‘000), Portugal, 2015
- Figure 65: Physicians (per 1,000 population), Portugal, 2010-2017
- Figure 66: Nurses (per 1,000 population), Portugal, 2010-2017
- Figure 67: Dentists, (per 1,000 population), Portugal, 2010-2017
- Figure 68: Pharmacists, (per 1,000 population), Portugal, 2010-2017
- Figure 69: PM2.5 (μg per m3), Portugal, 2010-2017
- Figure 70: CO2 Emissions (k tons), Portugal, 2010-2017
- Figure 71: Healthcare Expenditure (% of GDP), Portugal, 2010-2017
- Figure 72: Public-Private Share (%), Portugal, 2010-2017
- Figure 73: Major Components of Healthcare Spending (%), Portugal, 2015
- Figure 74: Trade Associations, Portugal
- Figure 75: Opportunities and Challenges, Portugal